(Q36467066)

14 August 2017

High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group (English)

1 reference

14 August 2017

1 reference

1 reference

1 reference

1

Postmus PE

1 reference

14 August 2017

Haaxma-Reiche H

2

1 reference

14 August 2017

Sleijfer DT

3

1 reference

14 August 2017

Kirkpatrick A

4

1 reference

14 August 2017

McVie JG

5

1 reference

14 August 2017

Kleisbauer JP

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 February 1989

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

59

1 reference

14 August 2017

254-256

1 reference

14 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1989.52

14 August 2017

0 references

cites work

The clinical pharmacology of VM26 and VP16-213. A brief overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246989

Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246989

CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246989

Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246989

Central nervous system metastases in small cell bronchogenic carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246989

High-dose etoposide for refractory malignancies: a phase I study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246989

Treatment of brain metastases of lung cancer with high doses of etoposide (VP16–213). Cooperative study from the groupe français pneumo-cancérologie

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246989

Brain metastases from small cell lung cancer treated with combination chemotherapy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246989

Results of whole-brain irradiation for metastases from small cell carcinoma of the lung

28 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2539174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of symptomatic and prophylactic irradiation of brain metastases from oat cell carcinoma of the lung

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2539174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2539174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1989.52

1 reference

14 August 2017

1 reference

14 August 2017

1 reference